22nd Century Group Inc
NASDAQ:XXII
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (10), the stock would be worth $31.94 (1 824% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | $1.66 |
0%
|
| Industry Average | 10 | $31.94 |
+1 824%
|
| Country Average | 14.4 | $45.93 |
+2 667%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$-4.7m
|
/ |
Jan 2026
$-10.5m
|
= |
|
|
$-4.7m
|
/ |
Dec 2026
$2.9m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
22nd Century Group Inc
NASDAQ:XXII
|
1.2m USD | 0.5 | -0.2 | |
| US |
|
Philip Morris International Inc
NYSE:PM
|
255.6B USD | 17 | 22.6 | |
| UK |
|
British American Tobacco PLC
LSE:BATS
|
94.5B GBP | 9.7 | 12.2 | |
| US |
|
Altria Group Inc
NYSE:MO
|
112B USD | 10.6 | 16.2 | |
| JP |
|
Japan Tobacco Inc
TSE:2914
|
10.3T JPY | 10.7 | 20.3 | |
| IN |
|
ITC Ltd
NSE:ITC
|
3.8T INR | 13.3 | 10.8 | |
| UK |
|
Imperial Brands PLC
LSE:IMB
|
22.4B GBP | 6.7 | 10.8 | |
| SE |
S
|
Swedish Match AB
F:SWMC
|
15.2B EUR | 19.9 | 25.4 | |
| KR |
|
KT&G Corp
KRX:033780
|
18.3T KRW | 11.2 | 16.8 | |
| CN |
|
Smoore International Holdings Ltd
HKEX:6969
|
58.9B HKD | 28.6 | 48.9 | |
| ID |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
83.2T IDR | 8.5 | 12.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
22nd Century Group Inc
Glance View
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. The company is headquartered in Williamsville, New York and currently employs 76 full-time employees. The company went IPO on 2006-10-17. The firm is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. In tobacco, hemp/cannabis, and hop plants, it uses various plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. The company has developed very low nicotine content (VLNC) tobacco and cigarettes, which contain 95% less nicotine than conventional tobacco and cigarettes. Its reduced nicotine cigarettes include VLN King and VLN Menthol King. In hemp, the Company is developing hemp varieties with increased levels of certain cannabinoids and other desirable agronomic traits.
